Fortress Wealth Group, LLC Bristol Myers Squibb CO Transaction History

Fortress Wealth Group, LLC

  • $194 Million
  • Q2 2024

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 07, 2023
BUY
$68.48 - $81.09 $191,538 - $226,808
2,797 New
2,797 $201,000
Q2 2022

Aug 15, 2022
BUY
$72.62 - $79.98 $145 - $159
2 Added 0.07%
2,899 $223,000
Q1 2022

May 16, 2022
SELL
$61.48 - $73.72 $16,292 - $19,535
-265 Reduced 8.38%
2,897 $212,000
Q4 2021

Feb 11, 2022
BUY
$53.63 - $62.52 $169,578 - $197,688
3,162 New
3,162 $212,000
Q3 2021

Nov 04, 2021
SELL
$59.17 - $69.31 $189,403 - $221,861
-3,201 Closed
0 $0
Q2 2021

Aug 13, 2021
BUY
$61.91 - $67.42 $198,173 - $215,811
3,201 New
3,201 $214,000

Others Institutions Holding BMY

# of Institutions
2,428
Shares Held
1.5B
Call Options Held
29.7M
Put Options Held
32.2M
View Full List

About BRISTOL MYERS SQUIBB CO

BMY Quotes by TradingView
  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $113B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Fortress Wealth Group, LLC Portfolio

Follow Fortress Wealth Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fortress Wealth Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fortress Wealth Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email